Proteasome protease mediated regulation of cytokine induction and inflammation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 11, 2012, Pages 2087-2093

  Qureshi, Nilofer ^a   Morrison, David C ^a   Reis, Julia ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Cytokines; LMP knockout mice; Proteasome; Proteasome inhibitors; Quercetin; Resveratrol

Indexed keywords

ADENOSINE A2A RECEPTOR; ADRENOMEDULLIN; CHYMOTRYPSIN; CILASTATIN PLUS IMIPENEM; COMPLEMENT COMPONENT C3; CXCL9 CHEMOKINE; CYCLIN D2; ENDOTHELIN 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; LACTACYSTIN; LIPOPOLYSACCHARIDE; MEVINOLIN; PROSTAGLANDIN SYNTHASE; PROTEASOME INHIBITOR; PROTEIN BCL 3; PROTEINASE INHIBITOR; QUERCETIN; RESVERATROL; STAT5A PROTEIN; TRANSCRIPTION FACTOR MAFF; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UBIQUITIN; VASCULAR CELL ADHESION MOLECULE 1;

AGING; ANIMAL EXPERIMENT; ANTIBIOTIC THERAPY; CELL METABOLISM; CYTOKINE PRODUCTION; DIET; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC DISORDER; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RED WINE; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SPLEEN CELL; UBIQUITINATION;

ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX;

MURINAE; MUS;

EID: 84866986070     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.06.016     Document Type: Review

References (34)

1. Qureshi N., Vogel S.N., Van Way C., Papasian C.J., Qureshi A.A., Morrison D.C. The proteasome. A central regulator of inflammation and macrophage function. Immunol. Res. 2005, 31:243-260.
2. Qureshi N., Perera P.-Y., Splitter G., Morrison D.C., Vogel S.N. The proteasome as a LPS-binding protein in macrophages. Toxic lipopolysaccharide activates the proteasome complex. J. Immunol. 2003, 171:1515-1525.
3. Shen J., Reis J., Morrison D.C., Papasian C., Raghavaikaimal S., Kolbert C., Qureshi A.A., Vogel S.N., Qureshi N. Key inflammatory signaling pathways are regulated by the proteasome. Shock 2006, 25:472-484.
4. Shen J., Gao J.J., Zhang G., Tan X., Morrison D.C., Papasian C.J., Vogel S.N., Qureshi N. Proteasome inhibitor, lactacystin blocks CpG DNA- and peptidoglycan induced inflammatory genes, cytokines and mitogen-activated protein kinases in macrophages. Shock 2006, 25:594-599.
5. Gao J.J., Shen J., Kolbert C., Raghavakaimal S., Papasian C.J., Qureshi N., Vogel S.N., Morrison D.C., Qureshi N. The proteasome regulates bacterial CpG DNA-induced signaling pathways in murine macrophages. Shock 2010, 34:390-401.
6. Reis J., Tan X., Yang R., Rockwell C.E., Papasian C.J., Vogel S.N., Morrison D.C., Qureshi A.A., Qureshi N. A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model. Innate Immun. 2008, 14:319-329.
7. Reis J., Guan X.-G., Kisselev A.F., Papasian C.J., Qureshi A.A., Morrison D.C., Van Way C.W., Vogel S.N., Qureshi N. LPS-induced formation of immunoproteasomes: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites. Cell Biochem. Biophys. 2011, 60:77-88.
8. Reis J., Hassan F., Guan X.-Q., Shen J., Monaco J.J., Papasian C.J., Qureshi A.A., Van Way C.W., Morrison D.C., Vogel S.N., Qureshi N. The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages. Cell Biochem. Biophys. 2011, 60:119-126.
9. Perkins D., Qureshi N., Vogel S.N. A TLR-responsive kinase, protein kinase R (Pkr), is inactivated in endotoxin tolerance through differential K63/K48 ubiquitination. Mbio 2010, 1:e00239-e002310.
10. Rockwell C.E., Qureshi N. Differential effects of lactacystin on cytokine production in activated Jurkat cells and murine splenocytes. Cytokine 2010, 51:12-17.
11. Rockwell C.E., Morrison D.C., Qureshi N. Lipid A-mediated tolerance and cancer therapy. Adv. Exp. Med. Biol. 2009, 667:81-99.
12. Gaczynska M., Goldberg A.L., Tanaka K., Hendil K.B., Rock K.L. Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-γ-induced subunits LMP2 and LMP7. J. Biol. Chem. 1996, 271:17275-17280.
13. Elenich L.A., Nandi D., Kent A.E., McCuskey T.S., Cruz M., Lyer M.N., Woodward E.C., Conn C.W., Ochoa A.L., Ginsburg D.B., Monaco J.J. The complete primary structure of mouse 20S proteasomes. Immunogenetics 1999, 49:835-842.
14. Dahlman B., Hendil K.B., Kristensen P., Uerkvitz W., Sobek A., Kopp F. Subunit arrangement in the human proteasome. Proteasomes; The World of Regulatory Proteolysis 2000, 37-47. Landes Bioscience, Georgetown, Texas. W. Hilt, D.H. Wolf (Eds.).
15. Kloetzel P.M., Ossendorp F. Proteasome and peptidase function in MHC class I-mediated antigen presentation. Curr. Opin. Immunol. 2004, 16:76-81.
16. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freundenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
17. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2000, 20:197-216.
18. Vogel S.N., Fitzgerald K.A., Fenton M.J. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 2003, 3:466-477.
19. O'Neill L.A., Bryant J.C.E., Doyle S.I. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol. Rev. 2009, 61:177-197.
20. Wertz I.E., Dixit V.M. Signaling to NF-κB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol. 2010, 2:a003350.
21. Palombella V.J., Rando O.J., Goldberg A.L., Maniatis T. The ubiquitin proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 1994, 78:773-785.
22. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103:351-361.
23. Abott D.W., Yang Y., Hutti J.E., Madhavarapu S., Kelliher M.A., Cantley L.C. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol. Cell. Biol. 2007, 27:6012-6025.
24. Schauvilege R., Janssens S., Beyaert R. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. FEBS Lett. 2006, 580:4697-4702.
25. Aisling D., Carpenter S., Brikos C., Gray P., Strelow A., Wesche H., Morrice N., O'Neill L.A.J. IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal). J. Biol. Chem. 2010, 285:18276-18282.
26. Higgs R., Gabhann J.N., Larbi N.B., Breen E.P., Fitzgerald K.A., Jefferies C.A. The E3 ubiquitin ligase Ro52 negatively regulates IFN-β production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 2008, 181:1780-1786.
27. Rockwell C.E., Monaco J.J., Qureshi N. A Critical Role for the Inducible Proteasomal Subunits LMP7 and MECL1 in Cytokine Production by Activated Murine Splenocytes. Pharmacology 2012, 89:117-126.
28. Kutuzova G.D., Albrecht R.M., Erickson C.M., Qureshi N. Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells. J. Immunol. 2001, 167:482-489.
29. Kagan J.C., Su T., Hornig T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat. Immunol. 2008, 9:361-368.
30. 1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. PNAS 1999, 96:7797-7802.
31. Qureshi A.A., Tan X., Reis J.C., Badr M.Z., Papasian C.J., Morrison D.C., Qureshi N. Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin. Lipids Health Dis. 2011, 10:239.
32. Qureshi A.A., Reis J., Qureshi N., Papasian C.J., Morrison D.C., Schaefer D.M. δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids Health Dis. March 2011, 10:39.
33. Qureshi A.A., Tan X., Reis J., Badr M.Z., Papasian C.J., Morrison D.C., Qureshi N. Suppression of nitric oxide production and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models. Lipids Health Dis. 2011, 10:177.
34. Qureshi A.A., Guan X.-Q., Reis J.C., Papasian C.J., Jabre S., Morrison D.C., Qureshi N. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by Resveratrol, a potent proteasome inhibitor. Lipids Health Dis. 2012, 11:76.